|
|
||||||||
University of California, San Francisco, California
University of Basel, Basel, Switzerland
University of Miami, Miami, Florida
The Transatlantic Airways Conference is held on an annual basis to review recent advances in the study of airway biology. Each conference is expected to meet three principal objectives:
First, it is given the task of summarizing current knowledge and suggesting new investigative approaches to increase our understanding of fundamental mechanisms in airway biology. Second, the conference should assemble a large interdisciplinary group of scientists from within and outside the pulmonary research community. Finally the conference should serve as a forum for exchange of ideas among investigators representing different countries. Free discussion forms the basis of the conference, with short presentations and extensive debate.
In keeping with these guiding principles, the 19th conference reviewed the state-of-the-art in the delivery of drugs and genes to the lung, with a focus on the inhaled route. Sir Colin Dollery, the conference chair, pulled together experts in gene therapy, aerosol physiology, receptor distribution in the airways, airway epithelial function and related fields, and skillfully initiated lively discussions. The conference provided an overview of past and recent advances in drug and gene delivery to the lung, and identified physical and biological barriers that have to be overcome to ensure future progress. The papers included in this volume are a reflection of the topics discussed by the conference participants.
The Scientific Committee thanks the following participants: E. Alton, P. Barnes, R. C. Boucher, K. L. Brigham, P. Byron, H. Derendorf, Sir C. Dollery, M. B. Dolovich, S. Farrow, P. Gehr, J. Heyder, S. T. Holgate, S. B. Liggett, J. Lötvall, W. Martin, V. R. Muzykantov, C. O'Callaghan, J. Patton, R. J. Pickles, G. Santis, J. Stolk, P. Ventresca, E. Wagner, S. T. Weiss, and J. M. Wilson. The committee also thanks B. Disse, B. Jung, D. Wiese and the Boehringer-Ingelheim Company for their continuing generous support of this series of scientific conferences.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |